Description
Sodium Starch Glycolate BP/USP (CAS: 9063-38-1) is a high-purity, pharmaceutical-grade superdisintegrant widely utilized in tablet and capsule formulations. Chemically defined as the sodium salt of a carboxymethylated cross-linked starch, it is specifically engineered to overcome the binding forces within solid oral dosage forms, ensuring rapid drug release and optimal bioavailability.
Key Features & Functional Benefits
Rapid Water Absorption & Swelling: Sodium Starch Glycolate acts predominantly through rapid hydration. Upon exposure to liquid, the cross-linked starch particles swell exponentially—up to 200–300 times their original volume—without forming a viscous gel barrier that could retard drug dissolution.
Effective at Low Concentrations: Highly efficient even at low inclusion levels (typically 2% to 8% of total formulation weight), making it cost-effective for direct compression, wet granulation, and dry granulation processes.
Broad pH Stability & Incompatibility Resistance: Maintains high swelling capacity across a wide pH range, functioning reliably in acidic gastric conditions as well as intestinal environments.
BP/USP Pharmacopeial Compliance: Manufactured under strict cGMP standards to meet both British Pharmacopoeia (BP) and United States Pharmacopeia (USP) monographs, ensuring high consistency, controlled pH, and low heavy-metal/microbial limits.
Applications in Pharmaceutical & Nutraceutical Manufacturing
Immediate-Release Tablets: Serves as the primary superdisintegrant in direct-compression and wet-granulated tablets requiring fast onset of action (e.g., analgesics, antibiotics, cardiovascular drugs).
Hard Gelatin Capsules: Promotes quick disintegration and shell opening to release active pharmaceutical ingredients (APIs) uniformly.
Nutraceuticals & Dietary Supplements: Ensures compliant disintegration times for vitamin blends, mineral complexes, and herbal extract tablets.









Reviews
There are no reviews yet.